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Adverse Maternal Outcomes in Nevada:

cavity (OR [CI] 2.15 [1.29, 3.58]), and cesarean
section (OR [CI] 1.87 [1.56, 2.23] ).

Does Asthma Matter?

Conclusion. Women with asthma experienced a
Jay J. Shen, Ph.D.

greater risk of having adverse maternal outcomes.
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should be supported to educate pregnant women
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about the potential risk factors and the relationship
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between asthma and maternal outcomes.
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Introduction
Asthma, a common chronic disease, has

Hong Wei, M.S., M.Math.

become more prevalent in recent years (Bhatnagar

School of Community Health Sciences

& Givelber 1999). The self-reported prevalence

University of Nevada, Las Vegas

rate increased from 3.1% (6.8 million) to 5.6%
(14.9 million) in the general population from the

Robin Mukalian, B.S.

early 2000’s to the mid-2000’s (Moorman, et al

Department of Health Care Administration and

2007). The National Health Interview Survey Data

Policy

for lifetime and current asthma (NHIS Data 2006)

School of Community Health Sciences

report that asthma prevalence percent is 7.8% (22.9

University of Nevada, Las Vegas

million) in 2006 in the United States (Center for
Disease Control 2009). According to findings of a
large prospective cohort study conducted in the

Abstract
Objective.

Asthma

clinical

northeastern United States, the prevalence rate of

complication of pregnancy and women with asthma

asthma was 8.4% among the pregnant population

are at greater risk of having complications. This

making it one of the most common clinical

study

complications

compared

is

adverse

a

common

maternal

outcomes

of

pregnancy

(Kwon,

Triche,

between women with asthma and women without

Belanger, & Bracken 2006). Uncontrolled asthma

asthma in Nevada.

events during pregnancy is related to a high risk of

Methods. A total of 64,664 hospital discharges of

certain adverse outcomes, such as intrauterine

delivery

growth restriction (Mabie, Barton,Wasserstrum, &

were

abstracted

from

the

Nevada

2003-2004 hospital discharges and thirteen adverse

Sabai

maternal

Logistic

Belanger, Leader, & Bracken 2004), hypertensive

regression was applied to compare the maternal

disorder of pregnancy, membrane-related disorders,

outcomes between women with and without

preterm

asthma.

cesarean delivery (Enriquez, et al 2007), as well as,

Results. Women with asthma were more likely to

adverse infant outcomes (Karimi, Davar, Mirzaei,

have pre-eclampsia (OR [CI] 1.73 [1.13, 2.65]),

& Mirzaei 2008).

outcomes

were

examined.

transient hypertension of pregnancy (OR [CI] 1.76

1992),

labor,

preeclampsia

antepartum

Whereas

most

of

(Triche,

Saftlas,

hemorrhage,

these

and

referenced

[1.11, 2.78]), pregnancy-induced hypertension (OR

studies are relatively limited in sample size, studies

[CI] 1.89 [1.42, 2.53]), gestational diabetes (OR

based on large sample size also have indicated

[CI] 1.89 [1.32, 2.72]), infection of the amniotic

associations between asthma and adverse maternal
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outcomes,

such

low

based on International Classification of Diseases,

induced

Ninth Edition, Clinical Modification (ICD-9-CM)

hypertension, hyperbilirubinemia, and an increased

Diagnostic Codes. Among the entire delivery cases,

rate of operative delivery (MacMullen, Tymkow, &

661 discharges with asthma were identified by

Shen 2006; Wen, DeMissie, & Liu 2001). These

ICD-9-CM diagnostic code of 463. The 2004

associations persist even when coexisting clinical

American Hospital Association (AHA) annual

conditions are taken into account (Sheiner, Mazor,

survey data was merged with the SID data by the

Levy, Wiznitzer, & Bashiri 2005). Finally, a

use of the AHA identification number to provide

meta-analysis concludes that uncontrolled asthma

hospital variables.

birth-weight,

as

fetal

premature
death,

delivery,

pregnancy

increases the risk of low birth weight, preterm
delivery,

and

complications

in

pregnancies

(Murphy, Gibson, Smith, & Clifton 2005).

Based on the literature (Liu, et al 2001;
MacMullen, Tymkow, & Shen 2006; Shen,
Tymkow, & MacMullun 2005), a total of thirteen

Given the limited number of comparison

adverse maternal outcome measures, being used as

studies focusing on asthma and adverse maternal

dependent variables, were investigated in this study.

outcomes in other parts of the nation, along with

They

the lack of literature that compares adverse

disorders of pregnancy (consisting of three

maternal

versus

measures:, pre-eclampsia, transient hypertension of

non-pregnant women in Nevada, our literature

pregnancy, and pregnancy-induced hypertension),

review suggests that this study would contribute to

gestational

a body of evidence which focuses on risk reduction

(including two measures:, placenta previa and

for pregnant women with asthma in the state.

abruptio placenta), membrane disorders (including

outcomes

of

pregnant

included

preterm

diabetes,

labor,

antepartum

hypertensive

hemorrhage

The purpose of this study was to

two measures:, premature rupture of membranes

examine whether adverse maternal outcomes

and infection of the amniotic cavity), cesarean

between women with asthma and women without

section, prolonged labor, postpartum hemorrhage,

asthma were different in Nevada, and to determine

and fetal death. Each dependant variable was coded

whether these findings were consistent with results

as a dummy variable with the value ―1‖ indicating

at the national level. Since asthma is a respiratory

an adverse outcome event, and the value ―0‖ as a

disease with symptoms of airway obstruction,

nonevent.

airway

airway

The primary independent variable was

responsiveness to a variety of stimuli, and smoking

inflammation

and

increased

asthma, with the value ―1‖ representing the

is a trigger of an asthma attack (NAEPP 2007),

pregnant woman with asthma as a comorbidity, and

from a health policy standpoint, implementation of

the value ―0‖ representing the pregnant woman

the Nevada Clean Indoor Air Act (NCIAA) may

without asthma.

have potential benefits of reducing the risk of

Multiple logistic regression was used to

smoke-triggered asthma, and in turn, improve

examine the relationship between the asthma

maternal outcomes in the state.

comorbidity during pregnancy, and each of the

Methods

thirteen adverse maternal outcome measures,

Data were abstracted from the Nevada 2003

respectively. The odds ratio (OR) was derived to

and 2004 State Inpatient Data (SID), available

approximate the risk ratio that indicated the risk of

through the Health Care Cost and Utilization

the adverse outcome anticipated among women

Project (HCUP), which is sponsored by the Agency

with

for Healthcare Research and Quality (AHRQ). A

-Covariates such as patient demographics, health

total of 64,664 pregnant women aged 13 or older

insurance

who delivered in 2003 and 2004 were selected

characteristics were controlled in the multivariable

asthma

over

status,

women

without

comorbidities,

and

asthma.
hospital
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analysis.

To

make

the

age

variable

more

meaningful, we defined seven dummy variables to

related to six of the thirteen adverse outcome
measures.

represent seven age groups (younger than 15 years

Table 2 shows the adjusted adverse

old, 15-19, 20-24, 25-29, 30-34, 35-39, and equal

maternal outcomes for women with asthma as

or older than 40 years), and the age group 25-29

compared with women without asthma. Women

was utilized as the reference group. The patient’s

with

residence was categorized as: large metropolitan

pre-eclampsia (OR [CI] 1.73 [1.13, 2.65]), transient

areas with at least one million residents, small

hypertension of pregnancy (OR [CI] 1.76 [1.11,

metropolitan areas with less than one million

2.78]), pregnancy-induced hypertension (OR [CI]

residents, micropolitan areas, and non-urban areas.

1.89 [1.42, 2.53]), gestational diabetes (OR [CI]

Hospital characteristics, such as size (i.e., large,

1.89 [1.32, 2.72]), infection of the amniotic cavity

medium, and small with small hospitals being the

(OR [CI] 2.15 [1.29, 3.58]), cesarean section (OR

reference) and teaching hospital status were

[CI] 1.87 [1.56, 2.23] ), and uterine tumor (OR [CI]

controlled. In addition, patient’s insurance status

2.75 [1.42, 5.30]).

was categorized as Medicare, Medicaid, private

Discussion

insurance, uninsured and other insurance with

asthma

In

were

Nevada,

more

likely

women

with

to

have

asthma

private insurance being the reference group. The

experienced a greater risk of having adverse

goodness-of-fit for the multivariable model for all

pregnancy outcomes than did women without

of the thirteen dependent variables, except for

asthma, after controlling for insurance status,

infection of the amniotic cavity and prolonged

maternal age, comorbidities, rural residence, and

labor, was greater than 0.05, which indicated good

hospital characteristics. Pregnant women with

model

asthma experienced more pre-eclampsia, transient

fit

for

most

of

the

variables

(Hosmer&Lemeshow 2000).

hypertension of pregnancy, pregnancy-induced

Results

hypertension, gestational diabetes, infection of the
About 1.03% of pregnant women, who

amniotic cavity, cesarean section, and uterine tumor.

delivered in a hospital environment, had asthma in

These findings were consistent with findings of

Nevada in 2003 and 2004. Table 1 shows the

prior studies in other parts of the country (Mabie, et

unadjusted descriptive results for the thirteen

al 1992; Sheiner, et al 2005; Triche, et al 2004),

patients’

including a study based on a national representative

socio-demographics. The average ages at delivery

sample (MacMullen, et al 2006), and the national

for women with and without asthma were similar.

guidelines of asthma diagnosis and treatment

The asthma group had a higher percentage of

(NAEPP 2007).

adverse

maternal

outcomes

and

women who resided in large urban areas, however,

More care is needed for women with asthma

it had lower rate for women who delivered in

during the delivery process due to related

teaching hospitals. The average length of stay for

complications. Asthma is associated with longer

women with asthma was 3.0 days and for women

hospital stay and consequently hospital charges for

without asthma, it was 2.2 days (p < 0.01). Total

the delivery process for women with asthma are

hospital charges for women with asthma were on

higher than women without asthma.

average $4,000 higher than the charges for women

Limitations inherent in the use of

without asthma (p < 0.01). Women with asthma

administrative data existed in this study. It was

experienced higher risk for all the thirteen adverse

unknown whether the circumstances of women

outcomes except prolonged labor and fetal death.

with asthma were under control or not. Infant

Results of the bivariate analysis indicated that

outcomes were not available in the SID dataset,

asthma was a statistically significant risk factor

either. In addition, the data we used in were almost
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six years old, trends of asthma and related

private sectors should support asthma related

complications can change during this period.

education programs available within community

Finally, information about patient severity of

and healthcare settings. Such programs will educate

asthma, regular outpatient care, medication use,

pregnant women and their families about the

and emergency room visits was unavailable.

association between asthma and maternal outcomes,

Nevertheless,

diagnostic

and the methods to assess the potential risk factors

information was one of the strengths of this study

such as smoking, respiratory infections, and other

as compared to those based on self-reported asthma.

asthma triggers that may lead to a severe attack.

Further, our findings provide a basic understanding

Patient education should include the avoidance of

of the relationship between asthma and adverse

risk factors and asthma self-management skills.

maternal outcomes in Nevada. Future research may

Finally, hospitals and other healthcare providers

compare

versus

should follow existing guidelines (NAEPP, 2007)

non-controlled asthma on maternal outcomes,

to manage the potential risk for pre-eclampsia,

examine the relationship between hospitals’ quality

transient

of care and maternal outcomes for women with

pregnancy-induced

asthma, or study the effects of patients’ factors on

diabetes, infection of the amniotic cavity, and the

maternal outcomes for women with asthma among

possibility of cesarean birth for women with

Nevada residents.

asthma during their pregnancy.

the

the

availability

effects

of

of

controlled

hypertension

hypertension,

Policy implications: Both public and
Table 1. Patients' Sociodemographic, Clinical, and Hospitalization Characteristics*
Women w/o Women with
Asthma

Asthma

Total

(n = 64003) (n=661)

(n = 64664) p-value

27.0 (6.1)

27.1 (6.4)

27.0 (6.1)

< 15

128(0.2)

1(0.2)

129(0.2)

15 - 19

7075(11.0) 82(12.4)

7157(11.1)

20 - 24

17042(26.6) 179(27.1)

17221(26.6)

25 - 29

17707(27.7) 152(23.0)

17859(27.6)

30 - 34

13955(21.8) 155(23.5)

14110(21.8)

35 - 39

6647(10.4) 74(11.2)

6721(10.4)

>= 40

1449(2.3)

1467(2.3)

Social demographics
Average age, year (St.d)
Age group

18(2.7)

Area of residence
Large metropolitan >= 1 million
residents

46952(73.4) 532(80.5)

47484(73.4)

11900(18.6) 53(8.0)

11953(18.5)

Micropolitan areas

2973(4.7)

50(7.6)

3023(4.7)

Non-urban

2017(3.2)

26(3.9)

2043(3.2)

Obesity

410(0.6)

30(4.5)

440(0.7)

Depression

224(0.4)

15(2.3)

239(0.4)

Small metropolitan < 1 million
residents

Comorbidities

of

pregnancy,
gestational
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Maternal outcomes (Table 1, con’t)
Pre-term labor

1906(3.0)

24(3.6)

1930(3.0)

0.33

1517(2.4)

26(3.9)

1543(2.4)

<0.01

Transient hypertension of pregnancy 1245(2.0)

26(3.9)

1271(2.0)

<0.01

Pregnancy-induced hypertension

3141(4.9)

67(10.1)

3208(5.0)

<0.01

1976(3.1)

40(6.1)

2016(3.1)

<0.01

Placenta previa

295(0.5)

6(0.9)

301(0.5)

0.09

Abruptio placenta

819(1.3)

11(1.7)

830(1.3)

0.38

Premature rupture of membrane

2066(3.2)

22(3.3)

2088(3.2)

0.88

Infection of the amniotic cavity

1005(1.6)

20(3.0)

1025(1.6)

<0.01

Hypertensive disorders of pregnancy
Pre-eclampsia

Gestational diabetes
Antepartum hemorrhage

Membrane disorders

Mode of Delivery
Cesarean section

18571(29.0) 310(46.9)

18881(29.2) <0.01

Prolonged labor

5344(8.4)

48(7.3)

5392(8.3)

0.31

Postpartum hemorrhage

1358(2.1)

17(2.6)

1375(2.1)

0.42

Uterine Tumor

404(0.6)

13(2.0)

417(0.6)

<0.01

Fetal death

257(0.4)

2(0.3)

259(0.4)

0.69

Average length of stay, day (St.d.)

2.2(2.0)

3.0(3.5)

2.2(2.0)

<0.01

Average total charges, $ (St.d)

8487(7296) 12115(13254) 8524(7390) <0.01

Median total charges, $

6938

9502

6959

Medicare

778(1.2)

8(1.2)

786(1.2)

Medicaid

19417(30.4) 198(30.1)

19615(30.4)

Private

36094(56.5) 414(62.9)

36508(56.6)

Uninsured

4665(7.3)

26(4.0)

4691(7.3)

Others

2893(4.5)

12(1.8)

2905(4.5)

Others

Hospitalization

Insurance

Hospital Characteristics
Teaching hospital

28560(44.7) 194(29.4)

28754(44.6)

Public

12231(19.2) 89(13.5)

12320(19.1)

Non for profit

21466(33.6) 196(29.7)

21662(33.6)

Profit

30180(47.3) 376(56.9)

30556(47.4)

Small hospital

19289(30.2) 246(37.2)

19535(30.3)

Medium hospital

5655(8.9)

5731(8.9)

Large hospital

38933(61.0) 339(51.3)

Ownership

Size
76(11.5)

39272(60.9)

St.d. - standard deviation
* Data are expressed as number and percentage unless otherwise indicated.
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Table 2. Relationships between Asthma and Adverse Maternal Outcomes of Women
(N = 64664)
Women w/o

Women

Asthma

Asthma

p-Value

c-Score

1.00

1.29(0.80, 2.12)

0.30

0.59

1.00

1.73(1.13, 2.65)

0.73

0.61

1.00

1.76(1.11, 2.78)

0.59

0.63

1.00

1.89(1.42, 2.53)

0.62

0.59

1.00

1.89(1.32, 2.72)

0.74

0.70

Placenta previa

1.00

1.79(0.83, 3.84)

0.84

0.67

Abruptio placenta‡

1.00

1.22(0.63, 2.35)

0.64

0.59

Premature rupture of membrane‡

1.00

1.04(0.64, 1.69)

0.20

0.58

Infection of the amniotic cavity‡

1.00

2.15(1.29, 3.58)

0.00

0.65

1.00

1.87(1.56, 2.23)

0.55

0.66

Prolong labor

1.00

0.99(0.71, 1.38)

0.01

0.63

Postpartum hemorrhage║

1.00

1.34(0.81, 2.21)

0.23

0.61

Uterine Tumor

1.00

2.75(1.42, 5.30)

0.64

0.81

Fetal death

1.00

0.69(0.17, 2.80)

0.21

0.64

Dependent Variable
Pre-term labor†

with

Goodness-Of-Fit

Hypertensive disorders of pregnancy
Pre-eclampsia‡
Transient

hypertension

of

pregnancy‡
Pregnancy-induced hypertension‡
Gestational diabetes§
Antepartum hemorrhage

Membrane disorders

Mode of Delivery
Cesarean section¶
Others

† adjusted for maternal age.
‡ adjusted for maternal age, gestational diabetes, pre-existing diabetes, and pre-existing hypertension.
§ adjusted for maternal age, gestational diabetes, and pre-existing hypertension.
¶ Risk Ratio, adjusted for ‡, plus pregnancy-induced hypertension, preterm labor, placenta previa, abrupture
placenta, premature, rupture of membrane, and infection of the amniotic cavity.
║adjusted for maternal age, coagulation disorders, uterine tumor, and cesarean section.
References

Hosmer, D.W. & Lemeshow, S. (2000). Applied

Bhatnagar, A. & Givelber, R. (1999). Dyspnea in

Logistic Regression. 2nd ed. New York: John

Pregnancy. Topics in Emergency Medicine, 21(4),

Wiley & Sons.

74.
Karimi, M., Davar, R., Mirzaei, J., & Mirzaei, M.
Enriquez, R., Griffin, M. R., Carroll, K. N.,

(2008). Pregnancy Outcomes in Asthmatic Women.

Pingsheng, W., Cooper, W. O., Gebretsadik, T.,

Iranian Journal of Allergy Asthma and Immunology,

Dupoint, W. D., Mitchel, E. F., & Hartert, T. V.

7(2), 105–106.

(2007). Effect of Maternal Asthma and Asthma
Control on Pregnancy and Perinatal Outcomes.

Kwon, H. L., Triche, E. W., Belanger, K., &

Journal of Allergy and Clinical Immunology,

Bracken, M. B. (2006). The Epidemiology of

120(3), 625-630.

Asthma During Pregnancy: Prevalence, Diagnosis

Nevada Journal of Public Health, (2010). Vol. 7 Shen et al., 33

and Symptoms. Immunology and Allergy Clinics of

National Institute of Health. (1993). Report of the

North America, 26(1), 29–62.

Working Group on Asthma and Pregnancy:
Management of Asthma During Pregnancy (NIH

Liu, S., Wen, S. W., DeMissie, K., Marcoux, S., &

Publication

Kramer, M. S. (2001). Maternal Asthma and

http://www.nhib-nihgov/health/prof/lung/lung/asth

Pregnancy Outcomes: A Retrospective Cohort

ma/astpreg.txt. Accessed on May 11, 2006.

Study.

American

Journal

of

Obstetrics

93-3279).

and

Gynecology, 184(2), 90-96.

Sheiner, E., Mazor, M., Levy, A., Wiznitzer, A., &

Mabie, W. C., Barton, J. R., Wasserstrum, N., &

Bashiri, A. (2005). Pregnancy Outcomes of

Sabai, B. M. (1992). Clinical Observations in

Asthmatic Patients: A Population-based Study.

Asthma and Pregnancy. Journal of Maternal Fetal

Journal of Maternal-Fetal and Neonatal Medicine,

Medicine, 1, 45–50.

18(4), 237–240.

MacMullen, N. J., Tymkow, C., & Shen, J. J.

Shen, J.J., Tymkow, C., & MacMullen, N. (2005).

(2006). Adverse Maternal Outcomes in Women

Disparities in Maternal Outcomes among

with Asthma: Differences by Race. Maternal and

Four Ethnic Populations. Ethnicity & Disease,

Child Nursing, 31(4), 263-268.

15(3), 492-497.

Moorman, J. E., Rudd, R. A., Johnson, C. A., King,

Triche, E. W., Saftlas, A. F., Belanger, K., Leader,

M., Minor, P., Bailey, C., Scalia, M. R., &

B. P., & Bracken, M. B. (2004). Association of

Akinbami, L. J. (2007). National Surveillance for

Asthma Diagnosis, Severity, and Treatment with

Asthma—United States, 1980–2004. MMWR:

Risk of Preeclampsia. Obstetrics and Gynecology,

CDC Surveill Summary, 56(8), 1-54.

104, 585–593.

Murphy, V. E., Gibson, P. G., Smith, R., & Clifton,

Wen, S. W., DeMissie, K., & Liu, S. (2001).

V.

Pregnancy:

Adverse Outcomes in Pregnancies of Asthmatic

Mechanisms and Treatment Implications. European

Women: Results from a Canadian Population.

Respiratory Journal, 25, 731–750.

Annals of Epidemiology, 11(1), 7-12.

L.

National

(2005).

Asthma

Asthma

During

Education

and

Prevention

Program (NAEPP). (2007). National Asthma
Education and Prevention Program Expert Panel
Report 3 - Guidelines for the
Diagnosis and Management of Asthma. National
Institute of Heart, Lung, and Blood, National
Institute of Health.
Center for Disease Control. (2009). National
Health Interview Survey (NHIS) Data - Population
Estimates and Prevalence Tables: 2006 Lifetime
and Current Asthma.
http://www.cdc.gov/asthma/nhis/06/data.htm.
Accessed on Jan 30, 2010.

